Skip to content

Clinical trials

Phase 1/2 Congenital Abnormalities trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital Abnormalities Phase: Phase 1/2 Country / region: France Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC1
Institut Paoli-Calmettes1
RHEACELL GmbH & Co. KG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital Abnormalities3
Leukemia2
Epidermolysis Bullosa1
Epidermolysis Bullosa Dystrophica1
Leukemia, Erythroblastic, Acute1
Leukemia, Megakaryoblastic, Acute1
Leukemia, Monocytic, Acute1
Leukemia, Myeloid, Acute1
Leukemia, Myelomonocytic, Acute1
Myelodysplastic Syndromes1

Trials

Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.